- Home
- RNR vs MEDP Comparison
RNR vs MEDP Comparison
Compare RNR & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNR
- MEDP
- Stock Information
- Founded
- RNR 1993
- MEDP 1992
- Country
- RNR Bermuda
- MEDP United States
- Employees
- RNR N/A
- MEDP N/A
- Industry
- RNR Property-Casualty Insurers
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- RNR Finance
- MEDP Health Care
- Exchange
- RNR Nasdaq
- MEDP Nasdaq
- Market Cap
- RNR 11.5B
- MEDP 13.4B
- IPO Year
- RNR 1995
- MEDP 2016
- Fundamental
- Price
- RNR $267.66
- MEDP $528.48
- Analyst Decision
- RNR Hold
- MEDP Hold
- Analyst Count
- RNR 13
- MEDP 11
- Target Price
- RNR $286.09
- MEDP $421.60
- AVG Volume (30 Days)
- RNR 440.4K
- MEDP 297.2K
- Earning Date
- RNR 10-28-2025
- MEDP 10-22-2025
- Dividend Yield
- RNR 0.60%
- MEDP N/A
- EPS Growth
- RNR N/A
- MEDP 26.42
- EPS
- RNR 39.14
- MEDP 13.46
- Revenue
- RNR $12,974,536,000.00
- MEDP $2,231,787,000.00
- Revenue This Year
- RNR N/A
- MEDP $19.06
- Revenue Next Year
- RNR $3.65
- MEDP $8.64
- P/E Ratio
- RNR $6.84
- MEDP $39.18
- Revenue Growth
- RNR 22.84
- MEDP 9.94
- 52 Week Low
- RNR $219.00
- MEDP $250.05
- 52 Week High
- RNR $300.00
- MEDP $547.15
- Technical
- Relative Strength Index (RSI)
- RNR 74.20
- MEDP 68.69
- Support Level
- RNR $255.00
- MEDP $484.00
- Resistance Level
- RNR $259.17
- MEDP $547.15
- Average True Range (ATR)
- RNR 4.91
- MEDP 13.13
- MACD
- RNR 2.15
- MEDP 0.92
- Stochastic Oscillator
- RNR 83.78
- MEDP 71.08
About RNR RenaissanceRe Holdings Ltd.
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.